KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Intuitive Surgical (ISRG) EBITDA (2016 - 2026)

Intuitive Surgical has reported EBITDA over the past 18 years, most recently at $799.7 million for Q1 2026.

  • Quarterly EBITDA rose 10.67% to $799.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.1 billion through Mar 2026, up 20.05% year-over-year, with the annual reading at $2.9 billion for FY2025, 25.4% up from the prior year.
  • EBITDA was $799.7 million for Q1 2026 at Intuitive Surgical, down from $864.3 million in the prior quarter.
  • Over five years, EBITDA peaked at $864.3 million in Q4 2025 and troughed at $279.1 million in Q2 2022.
  • The 5-year median for EBITDA is $512.1 million (2024), against an average of $539.7 million.
  • Biggest five-year swings in EBITDA: tumbled 46.47% in 2022 and later surged 63.24% in 2024.
  • Tracing ISRG's EBITDA over 5 years: stood at $372.5 million in 2022, then rose by 20.86% to $450.2 million in 2023, then soared by 63.24% to $734.9 million in 2024, then rose by 17.61% to $864.3 million in 2025, then fell by 7.47% to $799.7 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods came in at $799.7 million, $864.3 million, and $727.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.